Commonly reported side effects of palivizumab include: rhinitis.  See below for a comprehensive list of adverse effects.
Applies to palivizumab: intramuscular powder for solution, intramuscular solution
As well as its needed effects, palivizumab may cause unwanted side effects that require medical attention. 

If any of the following side effects occur while taking palivizumab, check with your doctor or nurse immediately:
Some palivizumab side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to palivizumab: intramuscular powder for injection, intramuscular solution
Frequency not reported: Arrhythmia (during studies of congenital heart disease patients)[Ref]
Common (1% to 10%): Nausea, vomiting, diarrhea[Ref]
Frequency not reported: Anaphylaxis, anaphylactic shock (sometimes fatal)Postmarketing reports: Angioedema[Ref]
Common (1% to 10%): Injection site reactions[Ref]
Very common (10% or more): Pyrexia[Ref]
Very common (10% or more): RashUncommon (0.1% to 1%): UrticariaFrequency not reported: Pruritus[Ref]
The most serious adverse reactions are anaphylaxis and other acute hypersensitivity reactions.[Ref]
Uncommon (0.1% to 1%): Thrombocytopenia (mild), eosinophilia (mild)Postmarketing reports: Severe thrombocytopenia (platelet count less than 50,000/microliter)[Ref]
Uncommon (0.1% to 1%): Convulsions[Ref]
Frequency not reported: Cyanosis during studies of congenital heart disease patientsPostmarketing reports: Dyspnea, asthma, bronchospasm[Ref]
1. "Product Information. Synagis (palivizumab)." Ross Product Division Pharmaceuticals, Columbus, OH. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
3. Boeckh M,  Berrey MM,  Bowden RA,  Crawford SW,  Balsley J,  Corey L "Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants." J Infect Dis 184 (2001): 350-4
4. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):
It is possible that some side effects of palivizumab may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Bluish color of the fingernails, lips, skin, palms, or nail beds
blurred vision
confusion
cough
difficulty with breathing
difficulty with swallowing
dizziness
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
fast heartbeat
fever
hives or welts
irregular, fast or slow, or shallow breathing
itching
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
loss of strength or energy
muscle pain or weakness
redness of the skin
shortness of breath
skin rash
sweating
tightness in the chest
unresponsiveness
unusual tiredness or weakness
wheezing


Black, tarry stools
bleeding gums
blood in the urine or stools
pinpoint red spots on the skin
unusual bleeding or bruising


Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

